Yue W, Li Y, Ou D, Yang Q
This nocebo effect can amplify subjective experiences of mild reactions
Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Think about itif a product contains fillers, contaminants, or has a broken peptide chain, its interaction with the digestive system becomes completely unpredictable
Fredrik Tiberg: Material science and things like porous media through complex fluids, Philip Hemme: but not necessarily pharma then, like Fredrik Tiberg: it was also No, I had a pretty broad repertoire